论文部分内容阅读
1988年1月～1996年3月间在Jichi或Hamamatsu医学院妇科49例卵巢恶性生殖细胞肿瘤和64例成熟良性囊性畸胎瘤于治疗前采取的血清样本,利用ELISA测定M-CSF,用放免法测定CA125。恶性肿瘤组:无性细胞瘤16例;起源于成熟囊性畸胎瘤的鳞状细咆癌16例;胚胎癌12例;未成熟畸胎瘤3级3例;卵黄囊瘤2例。按FIGO分期标准Ⅲ,23例Ⅰ期;8例Ⅱ期;14例Ⅲ期;4例Ⅳ期。MCSF血清基线水平为1056U/ml(均数±1.96SD),
Serum samples from 49 patients with ovarian malignant germ cell tumors and 64 mature benign cystic teratomas from July 1988 to March 1996 in gynecological department of Jichi or Hamamatsu Medical College were collected and tested for M-CSF by ELISA Radioimmunoassay CA125. Malignant tumor: 16 cases of dysgerminoma; 16 cases of squamous cell carcinoma of mature cystic teratoma; 12 cases of embryonic carcinoma; 3 cases of immature teratoma at grade 3; 2 cases of yolk sac tumor. According to FIGO staging standard Ⅲ, 23 cases of stage Ⅰ; 8 cases of stage Ⅱ; 14 cases of stage Ⅲ; 4 cases of stage Ⅳ. The baseline level of MCSF serum was 1056 U / ml (mean ± 1.96 SD)